US7189834B2
(en)
*
|
1993-05-11 |
2007-03-13 |
Marshall William E |
Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
|
US20030109469A1
(en)
*
|
1993-08-26 |
2003-06-12 |
Carson Dennis A. |
Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
|
US6727230B1
(en)
*
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US7935675B1
(en)
*
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US7422902B1
(en)
*
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
US5981501A
(en)
*
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
WO1998051278A2
(en)
*
|
1997-05-14 |
1998-11-19 |
Inex Pharmaceuticals Corporation |
High efficiency encapsulation of charged therapeutic agents in lipid vesicles
|
EP1674574A1
(en)
*
|
1998-05-14 |
2006-06-28 |
Coley Pharmaceutical GmbH |
Methods for Regulating Hematopoiesis using CpG-Oligonucleotides
|
SI1077722T1
(sl)
*
|
1998-05-22 |
2007-02-28 |
Ottawa Health Research Inst |
Metode in produkti za induciranje sluznicne imunosti
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US7776343B1
(en)
|
1999-02-17 |
2010-08-17 |
Csl Limited |
Immunogenic complexes and methods relating thereto
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
US20050002958A1
(en)
*
|
1999-06-29 |
2005-01-06 |
Smithkline Beecham Biologicals Sa |
Vaccines
|
ATE419869T1
(de)
|
1999-08-19 |
2009-01-15 |
Dynavax Tech Corp |
Methode zur modulierung eines immunantwortes mit immunstimulierenden sequencen und zusammensetzungen dafür
|
EE200200158A
(et)
*
|
1999-09-25 |
2003-06-16 |
University Of Iowa Research Foundation |
Immunostimulatoorsed nukleiinhapped
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
AU785212B2
(en)
*
|
1999-12-13 |
2006-11-09 |
Bioniche Life Sciences Inc. |
Therapeutically useful synthetic oligonucleotides
|
WO2001051500A1
(en)
*
|
2000-01-14 |
2001-07-19 |
The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
US6552006B2
(en)
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
US7585847B2
(en)
*
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
EP1259264A4
(en)
|
2000-02-23 |
2005-08-31 |
Univ California |
METHOD FOR THE TREATMENT OF INFLAMMATORY ENDURANCE AND OTHER FORMS OF GASTROINTESTINAL DEFICIENCY
|
US7129222B2
(en)
|
2000-03-10 |
2006-10-31 |
Dynavax Technologies Corporation |
Immunomodulatory formulations and methods for use thereof
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
AU5697001A
(en)
|
2000-03-31 |
2001-10-15 |
Purdue Research Foundation |
Method of treatment using ligand-immunogen conjugates
|
DE60100814T2
(de)
|
2000-06-08 |
2004-07-01 |
Intercell Biomedizinische Forschungs- Und Entwicklungs Gmbh |
Immunstimulierende oligodeoxynukleotide
|
EP1315672A4
(en)
|
2000-06-22 |
2006-04-26 |
Rxkinetix Inc |
ADMINISTRATIVE COMPOSITION COMPOSITION AND METHOD FOR THE ADMINISTRATION OF ANTIGENES AND OTHER ACTIVE SUBSTANCES
|
EP1296714B1
(en)
*
|
2000-06-22 |
2009-08-26 |
University Of Iowa Research Foundation |
Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer.
|
KR100917101B1
(ko)
*
|
2000-08-04 |
2009-09-15 |
도요 보세키 가부시키가이샤 |
플렉시블 금속적층체 및 그 제조방법
|
ATE510850T1
(de)
|
2000-09-15 |
2011-06-15 |
Coley Pharm Gmbh |
Verfahren zum hochdurchsatzscreening von auf cpg basierenden immunagonisten und -antagonisten
|
AU2001297693A1
(en)
*
|
2000-12-08 |
2002-09-12 |
Coley Pharmaceutical Gmbh |
Cpg-like nucleic acids and methods of use thereof
|
CA2430691A1
(en)
|
2000-12-27 |
2002-07-04 |
Dynavax Technologies Corporation |
Immunomodulatory polynucleotides and methods of using the same
|
US20030199466A1
(en)
|
2001-06-21 |
2003-10-23 |
Fearon Karen L. |
Chimeric immunomodulatory compounds and methods of using the same - ll
|
US7785610B2
(en)
*
|
2001-06-21 |
2010-08-31 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same—III
|
US20040132677A1
(en)
*
|
2001-06-21 |
2004-07-08 |
Fearon Karen L. |
Chimeric immunomodulatory compounds and methods of using the same-IV
|
WO2003002065A2
(en)
*
|
2001-06-29 |
2003-01-09 |
Chiron Corporation |
Hcv e1e2 vaccine compositions
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
CA2456328C
(en)
|
2001-08-07 |
2015-05-26 |
Dynavax Technologies Corporation |
Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof
|
AU2002361468A1
(en)
*
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
DE60229422D1
(de)
*
|
2001-08-17 |
2008-11-27 |
Coley Pharm Gmbh |
Kombinations-motif-immunstimulierende oligonukleotide mit verbesserter wirkung
|
AU2008200021A1
(en)
*
|
2001-08-17 |
2008-01-31 |
Coley Pharmaceutical Gmbh |
Combination motif immune stimulatory oligonucleotides with improved activity
|
BR0212366A
(pt)
|
2001-09-07 |
2004-07-27 |
Univ Boston |
Método e composição para tratar distúrbios associados com o complexo imune
|
JP4516748B2
(ja)
*
|
2001-09-14 |
2010-08-04 |
サイトス バイオテクノロジー アーゲー |
ウィルス様粒子中への免疫賦活物質のパッケージ化:調製法および使用法
|
ATE451935T1
(de)
*
|
2001-09-28 |
2010-01-15 |
Purdue Research Foundation |
Behandlungsverfahren mit liganden- immunogenkonjugaten
|
WO2003030656A2
(en)
|
2001-10-06 |
2003-04-17 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
AU2002360278A1
(en)
*
|
2001-10-12 |
2003-11-11 |
Coley Pharmaceutical Gmbh |
Methods and products for enhancing immune responses using imidazoquinoline compounds
|
US7276489B2
(en)
*
|
2002-10-24 |
2007-10-02 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
|
CA2472055A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Inex Pharmaceuticals Corporation |
Improved mucosal vaccines and methods for using the same
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
US7615227B2
(en)
*
|
2001-12-20 |
2009-11-10 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce angiogenesis
|
WO2003055514A1
(en)
|
2001-12-21 |
2003-07-10 |
Antigenics Inc. |
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
|
US8088388B2
(en)
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
EP1499187B1
(en)
|
2002-04-04 |
2015-06-17 |
Zoetis Belgium S.A. |
Immunostimulatory g,u-containing oligoribonucleotides
|
KR101092043B1
(ko)
*
|
2002-04-22 |
2011-12-12 |
바이오니취 라이프 사이언시즈 인코포레이티드 |
올리고뉴클레오티드 조성물 및 면역 반응 조절시 이의 용도
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
KR100456681B1
(ko)
|
2002-05-22 |
2004-11-10 |
주식회사 대웅 |
박테리아의 염색체 dna 파쇄물과 비독성리포폴리사카라이드를 포함하는 면역강화 및 조절 조성물
|
CA2388049A1
(en)
*
|
2002-05-30 |
2003-11-30 |
Immunotech S.A. |
Immunostimulatory oligonucleotides and uses thereof
|
ATE489969T1
(de)
*
|
2002-06-20 |
2010-12-15 |
Cytos Biotechnology Ag |
Verpackte virusartige partikel in kombination mit cpg zur verwendung als adjuvantien mit allergenen. herstellungsverfahren und verwendung
|
JP2005535627A
(ja)
*
|
2002-06-25 |
2005-11-24 |
シティ・オブ・ホープ |
アジュバント不含ペプチド・ワクチン
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
EP1551221A4
(en)
*
|
2002-07-03 |
2007-08-01 |
Coley Pharm Group Inc |
NUCLEIC ACID COMPOSITIONS FOR STIMULATING IMMUNE RESPONSES
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
US7576066B2
(en)
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
AR040996A1
(es)
*
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
SG166673A1
(en)
*
|
2002-08-19 |
2010-12-29 |
Coley Pharm Group Inc |
Immunostimulatory nucleic acids
|
MXPA05002791A
(es)
*
|
2002-09-13 |
2005-12-05 |
Replicor Inc |
Oligonucleotidos antivirales complementarios sin secuencia.
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
EA008777B1
(ru)
|
2002-10-29 |
2007-08-31 |
Коли Фармасьютикал Груп, Лтд. |
Способы и продукты, относящиеся к лечению и предупреждению инфекции вируса гепатита c
|
US7758876B2
(en)
|
2002-11-01 |
2010-07-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides
|
CA2502015A1
(en)
|
2002-12-11 |
2004-06-24 |
Coley Pharmaceutical Group, Inc. |
5' cpg nucleic acids and methods of use
|
TW201139672A
(en)
|
2002-12-13 |
2011-11-16 |
Novartis Ag |
Immunization of fish with plant-expressed recombinant proteins
|
WO2004058179A2
(en)
|
2002-12-23 |
2004-07-15 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
US8158768B2
(en)
*
|
2002-12-23 |
2012-04-17 |
Dynavax Technologies Corporation |
Immunostimulatory sequence oligonucleotides and methods of using the same
|
EP1625140A4
(en)
|
2002-12-23 |
2008-06-18 |
Dynavax Tech Corp |
BRANCHED IMMUNOMODULAR COMPOUNDS AND METHOD OF USE THEREOF
|
ES2385933T3
(es)
|
2003-02-20 |
2012-08-03 |
University Of Connecticut Health Center |
Métodos para la producción de complejos de moléculas antígenas de alfa (2) macroglobulina.
|
US7537767B2
(en)
|
2003-03-26 |
2009-05-26 |
Cytis Biotechnology Ag |
Melan-A- carrier conjugates
|
CA2517675A1
(en)
*
|
2003-03-26 |
2004-10-07 |
Cytos Biotechnology Ag |
Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
|
WO2004087203A2
(en)
*
|
2003-04-02 |
2004-10-14 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
ES2383367T5
(es)
*
|
2003-04-09 |
2021-03-31 |
Novartis Ag |
Aparato de pulverización en forma de aerosol con protección de entrada de aire
|
CN1798563A
(zh)
*
|
2003-05-15 |
2006-07-05 |
独立行政法人科学技术振兴机构 |
免疫刺激剂
|
WO2005007672A2
(en)
*
|
2003-06-20 |
2005-01-27 |
Coley Pharmaceutical Gmbh |
Small molecule toll-like receptor (tlr) antagonists
|
CN100404070C
(zh)
|
2003-07-10 |
2008-07-23 |
赛托斯生物技术公司 |
包装的病毒样颗粒
|
EP1666059A4
(en)
*
|
2003-08-11 |
2008-08-27 |
Univ Osaka Res Found |
NEW VACCINE WITH AN ADJUVANS FOR TRIGGERING ABSORBENT IMMUNITY
|
GB2388581A
(en)
|
2003-08-22 |
2003-11-19 |
Danisco |
Coated aqueous beads
|
DK1656026T3
(da)
|
2003-08-22 |
2014-07-14 |
Dupont Nutrition Biosci Aps |
Sammensætning, der omfatter et bakteriocin og et ekstrakt fra en plante fra læbeblomstfamilien
|
EP1670507A4
(en)
|
2003-09-12 |
2007-10-17 |
Antigenics Inc |
VACCINE FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY HERPES SIMPLEX VIRUS
|
JP4989225B2
(ja)
*
|
2003-09-25 |
2012-08-01 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
核酸親油性接合体
|
WO2005034979A2
(en)
*
|
2003-10-11 |
2005-04-21 |
Inex Pharmaceuticals Corporation |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
OA13278A
(en)
|
2003-10-30 |
2007-01-31 |
Coley Pharm Gmbh |
C-Class oligonucleotide analogs with enhanced immunostimulatory potency.
|
US20050239733A1
(en)
*
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
US20050100983A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Coley Pharmaceutical Gmbh |
Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling
|
CN101094594B
(zh)
*
|
2003-12-08 |
2012-08-15 |
海布里顿公司 |
通过基于小寡核苷酸的化合物调节免疫刺激性质
|
DE10361502A1
(de)
*
|
2003-12-23 |
2005-07-28 |
Phenion Gmbh & Co. Kg |
Kosmetische oder pharmazeutische Zubereitungen enthaltend Superstruktur-bildende Nukleinsäure-Sequenzen
|
KR100558851B1
(ko)
*
|
2004-01-08 |
2006-03-10 |
학교법인연세대학교 |
면역조절능력이 증가된 CpG 올리고데옥시뉴클레오티드변형체
|
US7973016B2
(en)
*
|
2004-01-23 |
2011-07-05 |
Joslin Diebetes Center |
Methods of treating, reducing, or preventing autoimmune conditions
|
TW200533750A
(en)
*
|
2004-02-19 |
2005-10-16 |
Coley Pharm Group Inc |
Immunostimulatory viral RNA oligonucleotides
|
WO2005111057A2
(en)
*
|
2004-04-02 |
2005-11-24 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for inducing il-10 responses
|
CA2567789A1
(en)
*
|
2004-06-08 |
2006-08-03 |
Coley Pharmaceutical Gmbh |
Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist
|
US7674456B2
(en)
*
|
2004-06-14 |
2010-03-09 |
Charles Wiseman |
Breast cancer cell lines and uses thereof
|
KR100958505B1
(ko)
|
2004-07-18 |
2010-05-17 |
씨에스엘 리미티드 |
면역자극 복합체 및 향상된 인터페론-감마 반응을 유도하기위한 올리고뉴클레오티드 제제
|
DE502005008794D1
(de)
*
|
2004-08-03 |
2010-02-11 |
Geneart Ag |
Verfahren zur modulation der genexpression durch änderung des cpg gehalts
|
DK1794174T3
(da)
|
2004-09-01 |
2012-07-09 |
Dynavax Tech Corp |
Fremgangsmåder og sammensætninger til hæmning af medfødte immunresponser og autoimmunitet
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
EP1657307A1
(en)
*
|
2004-11-16 |
2006-05-17 |
Immunotech S.A. |
Oligonucleotides that induce the secretion of GM-CSF
|
JP2008531018A
(ja)
*
|
2005-02-24 |
2008-08-14 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫刺激性オリゴヌクレオチド
|
JP5403457B2
(ja)
*
|
2005-02-28 |
2014-01-29 |
株式会社明治 |
Atオリゴヌクレオチドを有効成分とする免疫応答増強性薬剤及び食品組成物
|
NZ561144A
(en)
|
2005-03-04 |
2009-09-25 |
Dynavax Tech Corp |
Vaccines comprising oligonucleotides having immunostimulatory sequences (ISS) wherein the ISS are conjugated to antigens and stabilized by buffer conditions and further excipients
|
US7767212B2
(en)
|
2005-03-18 |
2010-08-03 |
Cytos Biotechnology Ag |
CAT allergen conjugates and uses thereof
|
EP1874325A2
(en)
*
|
2005-04-08 |
2008-01-09 |
Coley Pharmaceutical Group, Inc. |
Methods for treating infectious disease exacerbated asthma
|
US8642577B2
(en)
|
2005-04-08 |
2014-02-04 |
Chimerix, Inc. |
Compounds, compositions and methods for the treatment of poxvirus infections
|
BRPI0608170A2
(pt)
|
2005-04-28 |
2010-11-09 |
Novo Nordisk Healthcare Ag |
recipiente fechado contendo uma composição de um polipeptìdeo do fator vii ativado, processo para a preparação de um recipiente fechado contendo um polipeptìdeo do fator vii ativado, kit, e, método para a preparação de uma composição farmacêutica
|
DE102005022290A1
(de)
*
|
2005-05-13 |
2006-11-16 |
Universitätsklinikum Schleswig-Holstein |
Hexanukleotid-Wirkstoffe
|
CN1865275B
(zh)
*
|
2005-05-17 |
2011-06-15 |
长春华普生物技术有限公司 |
对人b细胞肿瘤有治疗作用的人工合成的单链脱氧核苷酸
|
EP2179737B1
(en)
|
2005-07-01 |
2013-08-14 |
Index Pharmaceuticals AB |
Modulating responsiveness to steroids
|
ES2450593T3
(es)
|
2005-07-01 |
2014-03-25 |
Index Pharmaceuticals Ab |
Método inmunoestimulante
|
AU2006269555A1
(en)
*
|
2005-07-07 |
2007-01-18 |
Coley Pharmaceutical Group, Inc. |
Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
|
EA013468B1
(ru)
*
|
2005-09-16 |
2010-04-30 |
Коли Фармасьютикал Гмбх |
Иммуностимулирующая одноцепочечная рибонуклеиновая кислота с фосфодиэфирным остовом
|
CN101321868A
(zh)
*
|
2005-09-16 |
2008-12-10 |
科利制药公司 |
通过核苷酸修饰调节短干扰核糖核酸(siRNA)的免疫刺激特性
|
WO2007050034A1
(en)
|
2005-10-28 |
2007-05-03 |
Index Pharmaceuticals Ab |
Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease
|
NZ567837A
(en)
|
2005-11-02 |
2011-11-25 |
Univ Texas |
Concurrent chemotherapy and immunotherapy with EGFRvIII peptide and temozolomide
|
ATE539765T1
(de)
|
2005-11-04 |
2012-01-15 |
Novartis Vaccines & Diagnostic |
Grippeimpfstoffe mit kombinationen aus teilchenförmigen adjuvantien und immunverstärkern
|
US10842867B2
(en)
|
2005-11-04 |
2020-11-24 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
AU2006310337B9
(en)
|
2005-11-04 |
2013-11-28 |
Novartis Ag |
Adjuvanted influenza vaccines including cytokine-inducing agents
|
NZ567978A
(en)
|
2005-11-04 |
2011-09-30 |
Novartis Vaccines & Diagnostic |
Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
|
CN102864152B
(zh)
*
|
2005-11-07 |
2015-11-18 |
艾德拉药物股份有限公司 |
包含经修饰的免疫刺激性二核苷酸的基于寡核苷酸的化合物之免疫刺激特性
|
ES2536103T3
(es)
|
2005-11-25 |
2015-05-20 |
Zoetis Belgium S.A. |
Oligorribonucleótidos inmunoestimuladores
|
US20070184068A1
(en)
|
2005-12-14 |
2007-08-09 |
Cytos Biotechnology Ag |
Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
|
EP1976559B3
(en)
|
2006-01-27 |
2020-02-19 |
Seqirus UK Limited |
Influenza vaccines containing hemagglutinin and matrix proteins
|
AU2007211334A1
(en)
*
|
2006-02-01 |
2007-08-09 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
WO2007092299A2
(en)
|
2006-02-03 |
2007-08-16 |
Purdue Research Foundation |
Targeted conjugates and radiation
|
CA2642152C
(en)
*
|
2006-02-15 |
2016-11-01 |
Coley Pharmaceutical Gmbh |
Compositions and methods for oligonucleotide formulations
|
CN100418583C
(zh)
*
|
2006-02-21 |
2008-09-17 |
朱鸿飞 |
预防和治疗乳腺炎的药物组合物
|
JP2009534303A
(ja)
|
2006-03-24 |
2009-09-24 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
冷蔵しないインフルエンザワクチンの保存
|
US9107863B2
(en)
*
|
2006-03-27 |
2015-08-18 |
The Buck Institute For Age Reasearch |
Reagents and methods for cancer treatment and prevention
|
WO2007126825A2
(en)
|
2006-03-31 |
2007-11-08 |
Novartis Ag |
Combined mucosal and parenteral immunization against hiv
|
JP5731115B2
(ja)
|
2006-05-05 |
2015-06-10 |
アイシス ファーマシューティカルズ, インコーポレーテッド |
遺伝子発現を調節するための化合物および方法
|
RU2464030C2
(ru)
*
|
2006-05-26 |
2012-10-20 |
Регадо Байосайенсиз, Инк. |
Введение противосвертывающей системы reg1
|
EP2035035A2
(en)
|
2006-06-09 |
2009-03-18 |
Novartis AG |
Immunogenic compositions for streptococcus agalactiae
|
NZ573622A
(en)
|
2006-06-12 |
2011-12-22 |
Cytos Biotechnology Ag |
Processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
|
MX2008016036A
(es)
|
2006-06-20 |
2009-04-07 |
Transgene Sa |
Vacuna viral recombinante.
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
CA3016948A1
(en)
|
2006-09-11 |
2008-03-20 |
Seqirus UK Limited |
Making influenza virus vaccines without using eggs
|
NZ575437A
(en)
|
2006-09-27 |
2012-02-24 |
Coley Pharm Gmbh |
Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
|
US20090142362A1
(en)
*
|
2006-11-06 |
2009-06-04 |
Avant Immunotherapeutics, Inc. |
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
|
EA200900784A1
(ru)
|
2006-12-06 |
2009-12-30 |
Новартис Аг |
Вакцины, включающие антиген из четырех штаммов вируса гриппа
|
UA100370C2
(uk)
|
2006-12-11 |
2012-12-25 |
Мериал Лимитед |
Спосіб вакцинації птахів проти salmonella
|
CA2671873C
(en)
|
2006-12-12 |
2018-10-09 |
Brian Stephen Sproat |
Oligonucleotides containing high concentrations of guanine monomers
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
EP2185191B1
(en)
|
2007-06-27 |
2012-09-12 |
Novartis AG |
Low-additive influenza vaccines
|
TR201000668T1
(tr)
*
|
2007-07-31 |
2010-06-21 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Neoplasti̇k veya enfeksi̇yoz bozukluklara yöneli̇k i̇mmunoprofi̇laksi̇ veya i̇mmünoterapi̇ i̇çi̇n poli̇pepti̇d-nüklei̇k asi̇t konjugati
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
AU2008317261B2
(en)
|
2007-10-26 |
2015-04-09 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
GB0818453D0
(en)
|
2008-10-08 |
2008-11-12 |
Novartis Ag |
Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
|
CN102670628B
(zh)
|
2008-01-25 |
2015-11-25 |
奇默里克斯公司 |
治疗病毒感染的方法
|
EP2889042A3
(en)
|
2008-03-18 |
2015-10-14 |
Novartis AG |
Improvements in preparation of influenza virus vaccine antigens
|
ES2760004T3
(es)
|
2008-05-08 |
2020-05-12 |
Boehringer Ingelheim Animal Health Usa Inc |
Vacuna contra Leishmania utilizando un inmunnógeno salival de mosca de la arena
|
TWI351288B
(en)
*
|
2008-07-04 |
2011-11-01 |
Univ Nat Pingtung Sci & Tech |
Cpg dna adjuvant in avian vaccines
|
JP5645840B2
(ja)
|
2008-12-02 |
2014-12-24 |
株式会社Wave Life Sciences Japan |
リン原子修飾核酸の合成方法
|
CA2745811C
(en)
*
|
2008-12-04 |
2021-07-13 |
Joseph Collard |
Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
|
US8552165B2
(en)
*
|
2008-12-09 |
2013-10-08 |
Heather Davis |
Immunostimulatory oligonucleotides
|
RU2477753C2
(ru)
|
2008-12-09 |
2013-03-20 |
Коули Фармасьютикал Груп, Инк. |
Иммуностимулирующие олигонуклеотиды
|
US9074210B2
(en)
*
|
2009-02-12 |
2015-07-07 |
Curna, Inc. |
Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
|
JP6066035B2
(ja)
*
|
2009-02-12 |
2017-01-25 |
クルナ・インコーポレーテッド |
グリア細胞由来神経栄養因子(gdnf)関連疾病の、gdnfに対する天然アンチセンス転写物の抑制による治療
|
ES2733084T3
(es)
|
2009-03-06 |
2019-11-27 |
Glaxosmithkline Biologicals Sa |
Antígenos de Chlamydia
|
US8883174B2
(en)
|
2009-03-25 |
2014-11-11 |
The Board Of Regents, The University Of Texas System |
Compositions for stimulation of mammalian innate immune resistance to pathogens
|
WO2010115118A2
(en)
|
2009-04-03 |
2010-10-07 |
Antigenics, Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
BRPI1013780B8
(pt)
|
2009-04-14 |
2022-10-04 |
Novartis Ag |
Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica
|
WO2010125461A1
(en)
|
2009-04-27 |
2010-11-04 |
Novartis Ag |
Adjuvanted vaccines for protecting against influenza
|
CN102596204B
(zh)
|
2009-07-06 |
2016-11-23 |
波涛生命科学有限公司 |
新的核酸前药及其使用方法
|
CA2767536A1
(en)
|
2009-07-07 |
2011-01-13 |
Novartis Ag |
Conserved escherichia coli immunogens
|
EP4218799A1
(en)
|
2009-07-15 |
2023-08-02 |
GlaxoSmithKline Biologicals S.A. |
Rsv f protein compositions and methods for making same
|
CA2768343A1
(en)
|
2009-07-16 |
2011-01-20 |
Novartis Ag |
Detoxified escherichia coli immunogens
|
CA2768947C
(en)
*
|
2009-07-24 |
2018-06-19 |
Opko Curna, Llc |
Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
|
DK2480669T3
(en)
*
|
2009-09-25 |
2018-02-12 |
Curna Inc |
TREATMENT OF FILAGGRIN- (FLG) RELATED DISEASES BY MODULATING FLG EXPRESSION AND ACTIVITY
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
CN108707584A
(zh)
|
2009-11-17 |
2018-10-26 |
Musc研究发展基金会 |
针对人核仁素的人单克隆抗体
|
US9683242B2
(en)
|
2009-11-23 |
2017-06-20 |
M.S. Technologies, Llc |
Herbicide tolerant soybean plants and methods for identifying same
|
KR101951958B1
(ko)
|
2009-11-23 |
2019-02-25 |
바이엘 크롭사이언스 엔.브이. |
우량 이벤트 ee-gm3, 그리고 생물학적 시료에서 이러한 이벤트를 동정하기 위한 방법 및 키트
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
E.coliキャリアタンパク質に結合体化した多糖免疫原
|
DK2534150T3
(en)
|
2010-02-12 |
2017-06-12 |
Chimerix Inc |
METHODS OF TREATING VIRUS INFECTION
|
WO2011139709A2
(en)
|
2010-04-26 |
2011-11-10 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
EA030620B1
(ru)
|
2010-05-26 |
2018-09-28 |
Селекта Байосайенсиз, Инк. |
Композиции для выработки иммунного ответа к наборам поверхностных антигенов, содержащие синтетические наноносители, и их применение
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
EA201291357A1
(ru)
|
2010-06-16 |
2013-11-29 |
Дайнэвокс Текнолоджиз Корпорейшн |
Способы лечения с применением ингибиторов tlr7 и/или tlr9
|
CN109112126A
(zh)
*
|
2010-06-23 |
2019-01-01 |
库尔纳公司 |
通过抑制电压门控钠通道α亚基(SCNA)的天然反义转录物而治疗SCNA相关疾病
|
RS54489B1
(en)
*
|
2010-07-06 |
2016-06-30 |
Glaxosmithkline Biologicals Sa |
LIPOSOMS WITH LIPIDS THAT HAVE IMPROVED PKA VALUE FOR RNA RELEASE
|
EP2620428B1
(en)
|
2010-09-24 |
2019-05-22 |
Wave Life Sciences Ltd. |
Asymmetric auxiliary group
|
WO2012061717A1
(en)
|
2010-11-05 |
2012-05-10 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
US10342862B2
(en)
|
2011-01-26 |
2019-07-09 |
Glaxosmithkline Biologicals, Sa |
RSV immunization regimen
|
US10941399B2
(en)
*
|
2011-04-14 |
2021-03-09 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for gene-specific demethylation by DNA methyltransferase (DNMT)-RNA interaction
|
LT3275892T
(lt)
|
2011-05-13 |
2020-04-10 |
Glaxosmithkline Biologicals S.A. |
Struktūros prieš suliejimą rsv f antigenai
|
HUE044062T2
(hu)
|
2011-05-20 |
2019-09-30 |
Alderbio Holdings Llc |
Anti-CGRP készítmények és alkalmazásuk
|
BR112013029959A8
(pt)
|
2011-05-20 |
2021-09-08 |
Alderbio Holdings Llc |
Anticorpos anti-cgrp e anti-cgrpr e seu uso para prevenir ou inibir fotofobia ou aversão à luz, composição farmacêutica compreendendo os referidos anticorpos, bem como sequência de ácido nucleico e célula recombinante
|
AU2012258976B8
(en)
|
2011-05-20 |
2017-07-20 |
H. Lundbeck A/S |
Use of anti-CGRP or anti-CGRP-R antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
|
CA2840965C
(en)
*
|
2011-07-06 |
2021-03-02 |
Novartis Ag |
Cationic oil-in-water emulsions
|
EP2729180B1
(en)
|
2011-07-08 |
2019-01-23 |
The University of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
JP6088507B2
(ja)
|
2011-07-08 |
2017-03-01 |
ノバルティス アーゲー |
チロシンライゲーションの方法
|
JP6128529B2
(ja)
|
2011-07-19 |
2017-05-17 |
ウェイブ ライフ サイエンシズ リミテッドWave Life Sciences Ltd. |
官能化核酸の合成のための方法
|
MX351642B
(es)
|
2011-07-20 |
2017-10-23 |
Merial Ltd |
Vacuna para virus de leucemia felina recombinante que contiene gen de envoltura del virus de leucemia felina optimizado.
|
US10933129B2
(en)
|
2011-07-29 |
2021-03-02 |
Selecta Biosciences, Inc. |
Methods for administering synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte responses
|
MX354924B
(es)
|
2011-11-07 |
2018-03-22 |
Novartis Ag |
Molecula portadora que comprende un antigeno spr0096 y un spr2021.
|
CN104520439A
(zh)
*
|
2012-02-28 |
2015-04-15 |
国立大学法人东京农工大学 |
Tdp-43细胞内存在量关联疾患的认定方法
|
AU2013235423B2
(en)
|
2012-03-20 |
2017-03-30 |
Boehringer Ingelheim Animal Health USA Inc. |
Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
|
JP2014012650A
(ja)
*
|
2012-07-05 |
2014-01-23 |
Nihon Univ |
上皮バリア機能の増強方法及び増強剤
|
WO2014012081A2
(en)
|
2012-07-13 |
2014-01-16 |
Ontorii, Inc. |
Chiral control
|
PL2872485T3
(pl)
|
2012-07-13 |
2021-05-31 |
Wave Life Sciences Ltd. |
Asymetryczna grupa pomocnicza
|
AU2013287630B2
(en)
*
|
2012-07-13 |
2017-05-25 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant
|
AU2013308623B2
(en)
|
2012-08-30 |
2017-03-02 |
Merial, Inc. |
Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
|
CN105307684A
(zh)
|
2012-10-02 |
2016-02-03 |
葛兰素史密丝克莱恩生物有限公司 |
非直链糖缀合物
|
RU2018137673A
(ru)
|
2012-11-30 |
2019-03-22 |
Глаксосмитклайн Байолоджикалс Са |
Антигены и комбинации антигенов pseudomonas
|
ES2730011T3
(es)
|
2013-02-20 |
2019-11-07 |
Innate Pharma |
Un compuesto que se une específicamente a KIR3DL2 para el uso en el tratamiento de linfoma de células T periférico
|
US9427647B2
(en)
*
|
2013-04-26 |
2016-08-30 |
Russell I. Moy |
Climbing hold assembly having load dissipative effect
|
WO2014191936A1
(en)
|
2013-05-29 |
2014-12-04 |
Institut National De La Sante Et De La Recherche Medicale |
Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomas
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
US10894963B2
(en)
|
2013-07-25 |
2021-01-19 |
Exicure, Inc. |
Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use
|
EP2870974A1
(en)
|
2013-11-08 |
2015-05-13 |
Novartis AG |
Salmonella conjugate vaccines
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
EP3095460A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
WO2015108047A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
US10160969B2
(en)
|
2014-01-16 |
2018-12-25 |
Wave Life Sciences Ltd. |
Chiral design
|
US10434064B2
(en)
|
2014-06-04 |
2019-10-08 |
Exicure, Inc. |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
EP3220895B1
(en)
|
2014-11-21 |
2022-08-31 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
CA2984643A1
(en)
|
2015-05-13 |
2016-11-17 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
KR20180035807A
(ko)
|
2015-06-26 |
2018-04-06 |
세퀴러스 유케이 리미티드 |
항원적으로 매치된 인플루엔자 백신
|
EP3468605A4
(en)
|
2016-06-08 |
2020-01-08 |
President and Fellows of Harvard College |
MODIFIED VIRAL VECTOR REDUCING THE INDUCTION OF INFLAMMATORY AND IMMUNE RESPONSES
|
TWI759317B
(zh)
*
|
2016-07-26 |
2022-04-01 |
德商拜耳動物保健有限公司 |
牛物種中增加的生育力
|
US11364304B2
(en)
|
2016-08-25 |
2022-06-21 |
Northwestern University |
Crosslinked micellar spherical nucleic acids
|
WO2018201090A1
(en)
|
2017-04-28 |
2018-11-01 |
Exicure, Inc. |
Synthesis of spherical nucleic acids using lipophilic moieties
|
US11433131B2
(en)
|
2017-05-11 |
2022-09-06 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (SNAs)
|
US11826426B2
(en)
|
2017-08-02 |
2023-11-28 |
The University Of Chicago |
Nanoscale metal-organic layers and metal-organic nanoplates for x-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and any combination thereof
|
US11981911B2
(en)
|
2017-11-08 |
2024-05-14 |
President And Fellows Of Harvard College |
Compositions and methods for inhibiting viral vector-induced inflammatory responses
|
CR20200260A
(es)
*
|
2017-12-15 |
2020-08-01 |
Bayer Animal Health Gmbh |
Composiciones inmunoestimulantes
|
SG11202106766SA
(en)
|
2019-01-08 |
2021-07-29 |
H Lundbeck As |
Acute treatment and rapid treatment of headache using anti-cgrp antibodies
|
AU2020403296A1
(en)
*
|
2019-12-13 |
2022-07-07 |
Grand Theravac Life Science (Nanjing) Co., Ltd. |
Immunostimulatory composition and use thereof
|
US20230241196A1
(en)
|
2020-01-27 |
2023-08-03 |
Oregon State University |
Gonorrhea subunit vaccine
|
CN114181888B
(zh)
*
|
2021-11-24 |
2023-12-08 |
汕头大学 |
一种浅色黄姑鱼鱼鳔细胞系的建立方法及应用
|
CN115252603A
(zh)
*
|
2022-07-08 |
2022-11-01 |
深圳市第二人民医院(深圳市转化医学研究院) |
indisulam在制备治疗膀胱癌的药物中的应用
|